American Renal Associates (ARA) Tops Q2 EPS by 4c

American Renal Associates (NYSE: ARA) reported Q2 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $187.6 million versus the consensus estimate of $187.63 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c